These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32378044)

  • 21. Neurologically Devastating Intraparenchymal Hemorrhage in COVID-19 Patients on Extracorporeal Membrane Oxygenation: A Case Series.
    Heman-Ackah SM; Su YS; Spadola M; Petrov D; Chen HI; Schuster J; Lucas T
    Neurosurgery; 2020 Aug; 87(2):E147-E151. PubMed ID: 32424429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guidance for anticoagulation management in venous thromboembolism during the coronavirus disease 2019 pandemic in Poland: an expert opinion of the Section on Pulmonary Circulation of the Polish Cardiac Society.
    Kosior DA; Undas A; Kopeć G; Hryniewiecki T; Torbicki A; Mularek-Kubzdela T; Windyga J; Pruszczyk P
    Kardiol Pol; 2020 Jun; 78(6):642-646. PubMed ID: 32515570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of heparin-induced thrombocytopenia in patients with 2019 coronavirus disease.
    Lozano R; Franco ME
    Med Clin (Barc); 2020 Nov; 155(9):409-410. PubMed ID: 32883507
    [No Abstract]   [Full Text] [Related]  

  • 24. Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?
    Cattaneo M; Bertinato EM; Birocchi S; Brizio C; Malavolta D; Manzoni M; Muscarella G; Orlandi M
    Thromb Haemost; 2020 Aug; 120(8):1230-1232. PubMed ID: 32349132
    [No Abstract]   [Full Text] [Related]  

  • 25. Pitfalls of Unfractionated Heparin Use During ST-Segment Elevation Myocardial Infarction in Patients With COVID-19 Infection.
    Martin AC; Godier A; Karam N
    J Am Coll Cardiol; 2021 Jan; 77(1):104. PubMed ID: 33413932
    [No Abstract]   [Full Text] [Related]  

  • 26. A matter of time: duration and choice of venous thromboprophylaxis in patients diagnosed with COVID-19.
    Kumar P; Mediwake R; Rhead C
    Br J Hosp Med (Lond); 2020 May; 81(5):1-2. PubMed ID: 32468942
    [No Abstract]   [Full Text] [Related]  

  • 27. [Recommendations for the use of thromboprophylaxis in hospitalized patients with COVID-19 in Argentina].
    Vazquez FJ; Korin J; Baldessari EM; Capparelli FJ; Gutierrez P; Pale C; Bocanegra F; Grand B; Penchasky D; Gonzalez Alcántara MM; Prémoli MS; Tabares A; Wainsztein N; Odetto D; Vaccaro C; Martínez Aquino E; Cumpian O; Falabella V; Antuel García S; Saadi J; Siccardi M; Gándara E
    Medicina (B Aires); 2020; 80 Suppl 3():65-66. PubMed ID: 32658849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy.
    Dragonetti D; Guarini G; Pizzuti M
    Blood Transfus; 2020 Jul; 18(4):328. PubMed ID: 32697931
    [No Abstract]   [Full Text] [Related]  

  • 29. COVID-19-associated coagulopathy: a concise review on pathogenesis and clinical implications.
    Memar Montazerin S; Najafi H; Shojaei F; Chi G; Goudarzi S; Sharfaei S; Kahe F; Hassanzadeh S
    Infez Med; 2021 Mar; 29(1):1-9. PubMed ID: 33664168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action.
    Pavoni V; Gianesello L; Pazzi M; Stera C; Meconi T; Frigieri FC
    Thromb Res; 2020 Dec; 196():313-317. PubMed ID: 32977129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sars-CoV-2 Induced Coagulopathy and Prognosis in Hospitalized Patients: A Snapshot from Italy.
    Giusti B; Gori AM; Alessi M; Rogolino A; Lotti E; Poli D; Sticchi E; Bartoloni A; Morettini A; Nozzoli C; Peris A; Pieralli F; Poggesi L; Marchionni N; Marcucci R
    Thromb Haemost; 2020 Aug; 120(8):1233-1236. PubMed ID: 32455440
    [No Abstract]   [Full Text] [Related]  

  • 32. Arterial thrombotic complications in hospitalized patients with COVID-19. Response to related letters.
    Rey JR; Merino JL; Iniesta ÁM; Caro-Codón J;
    Rev Esp Cardiol (Engl Ed); 2021 Jan; 74(1):116. PubMed ID: 33121911
    [No Abstract]   [Full Text] [Related]  

  • 33. Risk Benefit Analysis in Reference to use of LMWH in COVID-19.
    Samajdar SS; Sam PA; Moitra S; Ray Y; Pal J; Joshi SR; Tripathi SK
    J Assoc Physicians India; 2020 Sep; 68(9):52-61. PubMed ID: 32798346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracranial hemorrhage complicating anticoagulant prophylactic therapy in three hospitalized COVID-19 patients.
    Ghani MU; Kumar M; Ghani U; Sonia F; Abbas SA
    J Neurovirol; 2020 Aug; 26(4):602-604. PubMed ID: 32572835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticoagulation in COVID-19: It Is Time for High-Quality Evidence.
    Lopes RD; Fanaroff AC
    J Am Coll Cardiol; 2020 Oct; 76(16):1827-1829. PubMed ID: 33059827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute Limb Ischemia in Minimally Symptomatic SARS-CoV-2 Infection.
    Maurera AH; Vu JH; Rehring TF; Layman PF; Johnson SP
    J Vasc Interv Radiol; 2020 Dec; 31(12):2150-2153. PubMed ID: 33082089
    [No Abstract]   [Full Text] [Related]  

  • 37. Interpreting recent clinical studies for COVID-19: A continual process with more new data.
    Connors JM; Moll M; Levy JH
    Anaesth Crit Care Pain Med; 2022 Feb; 41(1):101016. PubMed ID: 34958999
    [No Abstract]   [Full Text] [Related]  

  • 38. [COVID-19 vaccine and anticoagulation patients at high cardiovascular risk. SEMERGEN recommendations].
    Pallarés-Carratalá V; Polo García J; Martín Rioboo E; Ruíz García A; Serrano-Cumplido A; Barrios V;
    Semergen; 2021; 47(1):1-3. PubMed ID: 33478841
    [No Abstract]   [Full Text] [Related]  

  • 39. Response to comment on 'SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung'.
    Mast AE; Wolberg AS; Gailani D; Garvin MR; Alvarez C; Miller JI; Jones P; Aronow B; Jacobson D
    Elife; 2022 Jan; 11():. PubMed ID: 35014952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study.
    Tomasoni D; Inciardi RM; Lombardi CM; Tedino C; Agostoni P; Ameri P; Barbieri L; Bellasi A; Camporotondo R; Canale C; Carubelli V; Carugo S; Catagnano F; Dalla Vecchia LA; Danzi GB; Di Pasquale M; Gaudenzi M; Giovinazzo S; Gnecchi M; Iorio A; La Rovere MT; Leonardi S; Maccagni G; Mapelli M; Margonato D; Merlo M; Monzo L; Mortara A; Nuzzi V; Piepoli M; Porto I; Pozzi A; Sarullo F; Sinagra G; Volterrani M; Zaccone G; Guazzi M; Senni M; Metra M
    Eur J Heart Fail; 2020 Dec; 22(12):2238-2247. PubMed ID: 33179839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.